Efficacy and Safety of Indacaterol, a New 24-hour β 2-Agonist, in Patients with Asthma: A Dose-Ranging Study

Author: Kanniess Frank   Boulet Louis-Philippe   Pierzchala Wladyslaw   Cameron Ray   Owen Roger   Higgins Mark  

Publisher: Informa Healthcare

ISSN: 0277-0903

Source: Journal of Asthma, Vol.45, Iss.10, 2008-12, pp. : 887-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content